Skip to main content

Advertisement

Table 3 Market dynamics for FDC versions of 3TC/NVP/d4T40, ABC/3TC/ZDV and EFV/FTC/TDF

From: Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets

  2004 2005 2006 2007 2008
3TC/NVP/d4T40:      
# Manufacturers * 2 5 3 4 3
# Approved Manufacturers
(WHO & FDA)
1 3 3 3 6
# Countries 21 38 32 21 7
Volume in person-years 55,758 126,005 114,178 103,690 14,810
Median annual price/person, USD (generic) 180 180 112 83 104
ABC/3TC/ZDV:      
# Manufacturers* 3 2 1 1 3
# Approved Manufacturers
(WHO & FDA)
1 1 1 1 2
# Countries 3 6 2 3 2
Volume in person-years 61 250 106 479 129
Median annual price/person, USD (brand) 1,483 1,366 1,363 883 3,257
EFV/FTC/TDF:      
# Manufacturers*     1 3
# Approved Manufacturers
(WHO & FDA)
   1 2 2
# Countries     1 7
Volume in person-years     335 3,720
Median annual price/person, USD (brand)     712 613
  1. * # of manufacturers refers to the number of manufacturers who sold ARVs to donor recipients in a given year, as reported to either GFATM or WHO; this is NOT the total # of manufacturers in the market